NIH Grants Exclusive License for Powered Walking Aids Tech
Published Date: 2/27/2026
Notice
Summary
The National Institutes of Health plans to give Bionic Power Inc. an exclusive license to use new technology that helps people walk better, especially those with movement problems. This means Bionic Power can develop and sell these powered gait assistance systems worldwide. If you want to comment or apply for a license, you need to act by March 16, 2026.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 1 costs, 1 mixed.
Exclusive License for Gait Devices
The National Institutes of Health is contemplating granting Bionic Power Inc. an exclusive, royalty-bearing patent license to practice listed inventions for "Powered Gait Assistance Systems". The prospective exclusive license territory may be worldwide where patent rights exist and the field of use is limited to "the treatment of human movement disorders."
Royalty Requirement and Confidentiality
The prospective exclusive license will be royalty-bearing. License applications filed in response to this notice will be presumed to contain business confidential information and will be released only as required under the Freedom of Information Act; public comments (not part of license applications) will not be treated confidentially and may be made publicly available.
Deadline to Apply or Comment
If you want to apply for a license or comment on the contemplated exclusive license, written comments and/or license applications must be received by the NCI Technology Transfer Center on or before March 16, 2026. Complete license applications timely filed will be treated as objections to the grant.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22871, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for eye disease, neuronal injury, infectious diseases, and related projects. No public access is allowed to protect private info and trade secrets, but these reviews help decide who gets research money.
2026-22550, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding two closed virtual meetings on November 30, 2026, to review important grant applications. These meetings affect researchers applying for funding in cardiovascular sciences and tobacco regulatory science. No public access is allowed to protect private info and trade secrets, and the reviews help decide who gets research money.
2026-22558, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for health-related projects, ensuring privacy for sensitive information. No direct money changes are announced, but these reviews help decide who gets research grants.
2026-22339, Prospective Grant of Exclusive Patent License: Catheter-Based Intramyocardial Ablation for Treating Ventricular Arrhythmia in a Human
The National Institutes of Health plans to give AntaraCore Systems, Inc. an exclusive license to use new catheter technology that treats dangerous heart rhythm problems called ventricular arrhythmia. This means AntaraCore will have special rights to develop and sell this life-saving treatment. If you want to comment or apply for a license, you must do so by December 2, 2026.
2026-22196, National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting
The National Institute of Diabetes and Digestive and Kidney Diseases is holding a public meeting on May 12, 2027, to discuss important council business and review grant applications. People interested can attend in person or online, but space is limited and some parts of the meeting will be private to protect sensitive information. This meeting affects researchers and organizations seeking funding and sets the stage for future diabetes and kidney disease research support.
2026-22111, Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting
The Eunice Kennedy Shriver National Institute of Child Health & Human Development is holding a virtual meeting on June 4, 2027, to share updates and review grant applications and staff performance. The first half is open to the public, while the second half is private to protect personal privacy. This meeting affects researchers and staff involved with NICHD grants and projects, with no direct cost changes announced.
Previous / Next Documents
Previous: 2026-03992, Meeting of the Great Lakes St. Lawrence Seaway Development Corporation (GLS) Advisory Board
The Great Lakes St. Lawrence Seaway Development Corporation is hosting a virtual public meeting on March 26, 2026, to discuss important updates and plans for the Seaway. Anyone interested, especially businesses and communities relying on the Seaway, can join, speak, or submit materials by early March. This meeting helps shape future decisions that could impact shipping and regional economies.
Next: 2026-03997, Submission for Review: 3206-0237, Information and Instructions on Your Reconsideration Rights, RI 38-47
The Office of Personnel Management is asking for public feedback on the instructions about how federal employees can ask for a second look at decisions about their retirement, health benefits, or life insurance. This update keeps the process clear and easy to follow, with no new costs or deadlines added. If you’re a federal employee or retiree, now’s the time to share your thoughts before April 28, 2026!